Preformed HLA Donor-Specific Antibodies Disappearance After Kidney Transplantation: Significance and Comparison with Persistent DSA

被引：0
|
作者：
Redondo, D. [1 ]
Perez-Saez, M. [1 ]
Mir, M. [1 ]
Gimeno, J. [1 ]
Garcia, C. [2 ]
Hernandez, J. [2 ]
Yalamos, J. [3 ]
Pascual, J. [1 ]
Crespo, M. [1 ]
机构：
[1] Hosp del Mar, Nephrol Dept, Barcelona, Spain
[2] Lab Referencia Catalunya, Barcelona, Spain
[3] IMIM, Barcelona, Spain
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B76
引用
收藏
页码：537 / 538
页数：2
相关论文
共 50 条
  • [31] Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney Transplantation
    Okabe, Y.
    Noguchi, H.
    Miyamoto, K.
    Kaku, K.
    Tsuchimoto, A.
    Masutani, K.
    Nakamura, M.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (10) : 3460 - 3466
  • [32] Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
    Lefaucheur, Carmen
    Loupy, Alexandre
    Hill, Gary S.
    Andrade, Joao
    Nochy, Dominique
    Antoine, Corinne
    Gautreau, Chantal
    Charron, Dominique
    Glotz, Denis
    Suberbielle-Boissel, Caroline
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (08): : 1398 - 1406
  • [33] The Effect of Preformed and De Novo Donor-Specific Antibodies (DSA) in Acute Rejection (AR) After Liver Transplantation (LTX)
    Koch, M.
    Runnebaum, M.
    Goebel, M.
    Thude, H.
    Sterneck, M.
    Marget, M.
    Nashan, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [34] Clinical relevance of de novo donor-specific HLA antibodies (DSA) in renal transplantation
    Sommer, Florian
    Kauke, Teresa
    Rueth, Stefan
    Anthuber, Matthias
    TRANSPLANTATION, 2016, 100 (07) : S615 - S615
  • [35] Donor-specific antibodies (DSA) in liver transplantation: Should DSA be considered?
    Helander, L.
    Roark, C. L.
    Freed, B.
    Adams, M.
    Wachs, M.
    Bock, M.
    HUMAN IMMUNOLOGY, 2023, 84 : 97 - 97
  • [36] Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies
    Itabashi, Yoshihiro
    Aikawa, Atsushi
    Muramatsu, Masaki
    Hyoudou, Youji
    Shinoda, Kazunobu
    Takahashi, Yusuke
    Sakurabayashi, Kei
    Mizutani, Toshihide
    Oguchi, Hideyo
    Arai, Taichi
    Kawamura, Takeshi
    Hamasaki, Yuko
    Sakai, Ken
    Shishido, Seiichiro
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2019, 17 : 43 - 49
  • [37] THE IMPACT OF PREFORMED AND DE NOVO DONOR-SPECIFIC HLA ANTIBODIES ON GRAFT REJECTION IN PATIENTS AFTER LIVER TRANSPLANTATION
    Kugyelka, Reka
    Kleid, Lisa
    Lutz, Teresa
    Denk, Gerald
    Guba, Markus
    Kauke, Teresa
    Dick, Andrea
    HLA, 2023, 102 : 15 - 16
  • [38] Induction Therapy Decreases the Risk of Rejection after Liver Transplantation in Patients with Preformed Donor-Specific HLA Antibodies
    Kaneku, Hugo
    O'Leary, Jacqueline G.
    Susskind, Brian M.
    Jennings, Linda W.
    Terasaki, Paul I.
    Klintmalm, Goeran B.
    LIVER TRANSPLANTATION, 2012, 18 : S86 - S86
  • [39] ARE IGM DONOR-SPECIFIC HLA ANTIBODIES (DSA) CLINICALLY RELEVANT?.
    Warner, Paul
    Gimferrer, Idoia
    Youngs, Danny
    Doran, Erin
    Ing, Aaron
    Arsenault, Kate
    Nelson, Karen
    HUMAN IMMUNOLOGY, 2015, 76 : 138 - 138
  • [40] THERAPEUTIC CONSEQUENCES OF SCREENING FOR DE NOVO DONOR-SPECIFIC HLA ANTIBODIES AFTER KIDNEY TRANSPLANTATION
    Cun, Hasret
    Honger, Gideon
    Amico, Patrizia
    Wehmeier, Caroline
    Steiger, Jurg
    Dickenmann, Michael
    Schaub, Stefan
    HLA, 2020, 95 (04) : 349 - 350
12345